Determining Risk Factors for Pellagra during the Isoniazid Preventive Therapy Scale-up in Malawi
Overview
Country:
Malawi
Subject Matter:
Adult Testing, Care, and Treatment
Data Collection Period: 02/2019 – 08/2019
The primary objective of this CDC-sponsored prospective study was to determine whether exposure to isoniazid (INH) is associated with the development of pellagra in Malawi.
Publications and Presentations
Paper published in Lancet Global Health May 2022: “Isoniazid-associated pellagra during mass scale-up of tuberculosis preventive therapy: a case-control study”
